HK1182397A1 - 新的八肽化合物及其在治療中的用途 - Google Patents

新的八肽化合物及其在治療中的用途

Info

Publication number
HK1182397A1
HK1182397A1 HK13109641.9A HK13109641A HK1182397A1 HK 1182397 A1 HK1182397 A1 HK 1182397A1 HK 13109641 A HK13109641 A HK 13109641A HK 1182397 A1 HK1182397 A1 HK 1182397A1
Authority
HK
Hong Kong
Prior art keywords
therapy
new
octapeptide compounds
compounds
new octapeptide
Prior art date
Application number
HK13109641.9A
Other languages
English (en)
Inventor
Jean-Christophe Cintrat
Melinda Ligeti
Bernard Rousseau
Franck Artzner
Christophe Tarabout
Marie-Thrse Paternostre
Nicolas Fay
Roland Cherif-Cheikh
Cline Valery
Original Assignee
Ipsen Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma Sas filed Critical Ipsen Pharma Sas
Publication of HK1182397A1 publication Critical patent/HK1182397A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK13109641.9A 2010-06-22 2013-08-19 新的八肽化合物及其在治療中的用途 HK1182397A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10290336A EP2399931A1 (fr) 2010-06-22 2010-06-22 Nouveaux composés octapeptidiques et leur utilisation thérapeutique
PCT/FR2011/000352 WO2011161332A1 (fr) 2010-06-22 2011-06-21 Nouveaux composés octapeptidiques et leur utilisation thérapeutique

Publications (1)

Publication Number Publication Date
HK1182397A1 true HK1182397A1 (zh) 2013-11-29

Family

ID=43066031

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13109641.9A HK1182397A1 (zh) 2010-06-22 2013-08-19 新的八肽化合物及其在治療中的用途

Country Status (8)

Country Link
US (1) US9040482B2 (zh)
EP (2) EP2399931A1 (zh)
JP (1) JP2013534920A (zh)
CN (1) CN102947332B (zh)
ES (1) ES2477615T3 (zh)
HK (1) HK1182397A1 (zh)
RU (1) RU2595525C2 (zh)
WO (1) WO2011161332A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9777039B2 (en) 2012-11-01 2017-10-03 Ipsen Pharma S.A.S. Somatostatin analogs and dimers thereof
CN109748824A (zh) * 2019-01-22 2019-05-14 康化（上海）新药研发有限公司 一种Nα-芴甲氧羰基-Nε-二甲基-赖氨酸盐酸盐的合成及纯化方法
CN110841607B (zh) * 2019-11-22 2020-07-24 中国科学院地质与地球物理研究所 一种超低本底金特效树脂及其制备和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体
GB9016885D0 (en) * 1990-08-01 1990-09-12 Scras Sustained release pharmaceutical compositions
HU224350B1 (hu) * 1993-08-09 2005-08-29 Société de Conseils de Recherches et d'ApplicationScientifiques, S.A.S. Á Gyógyhatású peptidszármazékok
AU3215597A (en) * 1996-08-30 1998-03-19 Biomeasure Incorporated Method of inhibiting fibrosis with a somatostatin agonist
ES2264174T3 (es) * 1996-12-04 2006-12-16 Societe De Conseils De Recherches Et D'applications Scientifiques (Scras) S.A.S Antagonistas de somatostatina.
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
US6387932B1 (en) * 1999-06-25 2002-05-14 Merck & Co., Inc. Somatostatin agonists
ES2306766T3 (es) * 2001-03-08 2008-11-16 The Administrators Of The Tulane Educational Fund Antagonistas de somatostatina.
EP2168983A1 (fr) * 2008-09-30 2010-03-31 Ipsen Pharma Nouveaux composés octapeptidiques et leur utilisation thérapeutique

Also Published As

Publication number Publication date
CN102947332A (zh) 2013-02-27
ES2477615T3 (es) 2014-07-17
JP2013534920A (ja) 2013-09-09
RU2013102588A (ru) 2014-07-27
EP2585486A1 (fr) 2013-05-01
US9040482B2 (en) 2015-05-26
CN102947332B (zh) 2017-03-01
EP2585486B1 (fr) 2014-05-14
WO2011161332A1 (fr) 2011-12-29
EP2399931A1 (fr) 2011-12-28
US20130252892A1 (en) 2013-09-26
RU2595525C2 (ru) 2016-08-27

Similar Documents

Publication Publication Date Title
IL221511A (en) Arilatriazolones associated with bis aryl and their use
EP2542086A4 (en) COMPOUNDS AND ITS THERAPEUTIC USE
IL222027A (en) Peptides and their use
GB201120993D0 (en) Novel compounds and their use in therapy
HK1195736A1 (zh) 放射免疫偶聯物和它們的用途
GB201004020D0 (en) New therapeutic use
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
HK1179997A1 (zh) 神經調節蛋白拮据劑及其在治療癌症中的使用
AP2013006947A0 (en) Compounds and their use
EP2575453A4 (en) OLIGO-BENZAMIDE COMPOUNDS AND THEIR USE
EP2817304A4 (en) NOVEL COMPOUNDS AND THEIR THERAPEUTIC USE
GB201011411D0 (en) Therapeutic compounds and their use
HK1182397A1 (zh) 新的八肽化合物及其在治療中的用途
GB0905970D0 (en) Depsipeptides and their therapeutic use
IL222870A0 (en) Use of ccl1 in therapy
GB201021425D0 (en) Drug composition and its use in therapy
GB201019971D0 (en) Drug composition and its use in therapy
GB201019972D0 (en) Drug composition and its use in therapy
GB201020792D0 (en) Peptide agents for use in therapy
GB201015789D0 (en) Peptides and their use in the treatment
HUP1000688A2 (en) Use of trifluoro-phthalimides in the treatment of cancer
GB0913300D0 (en) Therapeutic compounds and their use
GB201117876D0 (en) Peptides and their use in treatment
GB201001170D0 (en) Novel peptides and their use in therepy and diagnosis
GB201006918D0 (en) Glycosylated agents and their use in therapy

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: CORRECTION OF THE NAME OF APPLICANT FROM CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE(CNRS) TO THE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE(CNRS)

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210619